NCT04931485

Brief Summary

Background: Recent studies have questioned the safety of current fluid resuscitation strategies in patients with septic shock as prospective and observational data suggesting that the resulting fluid overload is associated with mortality. Two strategies have evolved to prevent or minimize fluid overload: restrictive fluid administration or active removal of accumulated fluid. While several small trials show benefits with a restrictive fluid administration regimen, active protocolized de-resuscitation was scarcely evaluated. The combination of both strategies yet warrants systematic evaluation. Aim: This study aims to assess the efficacy and feasibility of an early active de-resuscitation protocol in patients with septic shock. We hypothesize that the application of a structured early de-resuscitation protocol versus standard of care will lead to less fluid overload at day three after ICU admission. Study Intervention: Patients admitted to the ICU with confirmed or suspected septic shock (Sepsis-3 definition) will be randomized (1:1) to either the intervention or standard of care. In the intervention arm, patients are managed according to the REDUCE fluid management protocol during resuscitation and de-resuscitation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 18, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

July 19, 2021

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 7, 2025

Completed
Last Updated

May 5, 2026

Status Verified

April 1, 2026

Enrollment Period

3.6 years

First QC Date

May 14, 2021

Last Update Submit

April 28, 2026

Conditions

Keywords

Septic shockFluid resuscitation

Outcome Measures

Primary Outcomes (1)

  • Proportion of patient with a negative fluid balance on day 3

    Proportion of patients with a negative cumulative fluid balance on day 3

    Up to day 3 after ICU admission

Secondary Outcomes (8)

  • Number of patients with fluid overload at day 3 and ICU discharge

    From hospital admission to the end of ICU stay, on average after 7 days

  • Feasibility of the REDUCE fluid protocol

    From randomisation until the end of ICU stay, on average after 7 days

  • Incidence of ischemic events and severe AKI

    Ischemic events and AKI: From randomisation until the end of ICU stay (on average after 7 days), and at day 30; electrolyte and acid-base/medication associated safety endpoints: during ICU stay (on average 7 days)

  • Ventilator-free days at day 30

    Up to 30 days after randomisation

  • Vasopressor-free days at day 30

    Up to 30 days after randomisation

  • +3 more secondary outcomes

Other Outcomes (1)

  • Daily cumulative fluid balance up to day 7

    Throughout the ICU stay, on average 7 days

Study Arms (2)

Intervention: REDUCE Protocol

EXPERIMENTAL

Fluid resuscitation and de-resuscitation is based on the REDUCE fluid management protocol.

Other: Fluid management according to the REDUCE Fluid Protocol

Standard of Care

ACTIVE COMPARATOR

Fluid resuscitation and de-resuscitation according to the standard of care

Other: Standard of care

Interventions

Fluid management according to the protocol will be guided by pre-defined clinical signs for impaired perfusion and fluid overload.

Also known as: REDUCE protocol
Intervention: REDUCE Protocol

Fluid resuscitation and de-resuscitation will be managed according to the standard of care

Standard of Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients admitted to ICU with the diagnosis of septic shock as defined according to the Sepsis-3 criteria (suspected or confirmed infection AND vasopressor/inotrope ongoing to maintain MAP ≥ 65 mmHg AND Lactate ≥ 2 mmol/l in the last 6 hours

You may not qualify if:

  • Age \<18 years
  • Septic shock for more than 12 hours at the time of screening
  • Acute burn injury \>/= 10% of the body surface area
  • Known pregnancy or lactating women
  • Consent not obtainable due to national legislation
  • Patients on chronic dialysis
  • Patients that are known to be allergic to furosemide or metolazone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

University Hospital Basel

Basel, 4031, Switzerland

Location

University Hospital Bern, Inselspital

Bern, 3010, Switzerland

Location

Cantonal Hospital St. Gallen

Sankt Gallen, 9000, Switzerland

Location

Kantonsspital Winterthur

Winterthur, 8400, Switzerland

Location

Related Publications (1)

  • Messmer A, Pietsch U, Siegemund M, Buehler P, Waskowski J, Muller M, Uehlinger DE, Hollinger A, Filipovic M, Berger D, Schefold JC, Pfortmueller CA. Protocolised early de-resuscitation in septic shock (REDUCE): protocol for a randomised controlled multicentre feasibility trial. BMJ Open. 2023 Sep 21;13(9):e074847. doi: 10.1136/bmjopen-2023-074847.

    PMID: 37734896BACKGROUND

MeSH Terms

Conditions

Shock, Septic

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Anna S Messmer, MD

    Department of Intensive Care, Inselspital, Bern University Hospital, Bern, Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors will be blinded to the treatment allocation.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Patients will be randomized to receive either fluid resuscitation/de-resuscitation according to the REDUCE protocol or standard of care.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 14, 2021

First Posted

June 18, 2021

Study Start

July 19, 2021

Primary Completion

February 10, 2025

Study Completion

May 7, 2025

Last Updated

May 5, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations